Literature DB >> 23599596

Initial evaluation of inflammatory breast cancer with fluorodeoxyglucose positron emission tomography.

Sait Sager1, Sertac Asa, Rana Kaya Doner, Cem Leblebici, Metin Halac.   

Abstract

Inflammatory breast cancer (IBC) is the most aggressive form of locally advanced breast cancer. We present here (18)F FDG PET/CT findings of two patients with IBC. These patients were referred to the Nuclear Medicine department for staging of IBC. FDG PET/CT images showed diffuse infiltration of breasts with multiple lymph nodes and multiple metastases in whole-body PET/CT images. FDG PET provides additional information regarding lymph nodes or distant metastases in the initial evaluation of IBC.

Entities:  

Keywords:  Fluorodeoxyglucose; inflammatory breast cancer; positron emission tomography

Year:  2012        PMID: 23599596      PMCID: PMC3628259          DOI: 10.4103/0972-3919.108843

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


INTRODUCTION

Inflammatory breast cancer (IBC) is the most aggressive form of locally advanced breast cancer. Whole-body FDG-PET scans can characterize the extent of the pathologic involvement in IBC. The metabolic information from FDG PET is more sensitive than conventional imaging methods for the detection of loco-regional and distant metastases. We herein present two cases of 18F FDG PET/CT imaging findings of IBC.

CASE REPORT

Case 1

A 32-year-old female presented with diffuse right breast enlargement, redness, and peau d’orange form of breast. 18F FDG PET/CT whole-body imaging was performed after intravenously injection of 420 MBq (11,3 mCi) 18F FDG. After 1 hour of waiting period in a silent room the patient was imaged using an integrated PET/CT camera, which consisted of a six-slice CT gantry, integrated with an LSO based fullring PET scanner (Siemens Biograph 6, IL, Chicago, USA). Maximum-intensity-projection (MIP) of the PET image showed intense hypermetabolic activity involving the right breast with a maximal standardized uptake value (SUV) of 22.6 and multiple mediastinum, bilateral subclaviculary-axillary lymph nodes, bilateral liver lobes, and multiple skeletal metastatic lesions. The axial PET image showed intense FDG uptake in the right breast [Figure 1]. After the right breast skin biopsy, pathology results showed IBC [Figure 2].
Figure 1

FDG PET/CT images of a 32-year-old female patient with a inflammatory breast cancer. (a) Maximum-intensity-projection (MIP) of PET image. (b) Axial PET image. (c) Axial CT image

Figure 2

Pathology results showed infiltrative carcinoma cell (Hand E, ×200)

FDG PET/CT images of a 32-year-old female patient with a inflammatory breast cancer. (a) Maximum-intensity-projection (MIP) of PET image. (b) Axial PET image. (c) Axial CT image Pathology results showed infiltrative carcinoma cell (Hand E, ×200)

Case 2

A 51-year-old female patient referred to the Nuclear Medicine department for initial evaluation of bilateral IBC. Her sympyoms were bilateral breast enlargement, pain, and redness. Whole-body FDG PET/CT image was performed after intravenous injection of 510 MBq (13.7 mCi) 18F FDG. FDG PET images showed bilateral intense breast uptake with a maximum standardized uptake value of 15.6 and bilateral supraclavicular lymph nodes, multiple skeletal FDG uptakes were seen [Figure 3].
Figure 3

Whole-body FDG PET maximum-intensity-projection (MIP) of a 51-year-old female patient with an inflammatory breast cancer

Whole-body FDG PET maximum-intensity-projection (MIP) of a 51-year-old female patient with an inflammatory breast cancer

DISCUSSION

IBC is a rare but extremely aggressive form of invasive breast cancer that comprises 1-6% of breast cancer cases.[1] It tends to be diagnosed in younger women compared to non IBC and often metastasizes before it is diagnosed.[2] The prognosis is generally not as good as like other types of breast cancer. The combination of PET and computed tomography (PET/CT) allows the functional PET and anatomical CT images to be acquired under identical conditions and then they are rapidly coregistered.[3] The major roles for PET/CT in breast cancer are detecting and localizing metastasis, monitoring the response to treatment, and early detection of recurrence.[4] FDG PET/CT imaging provides additional information regarding lymph node or distant metastases in IBC patients and should be considered in the initial staging.[56] Carkaci et al., reported that among 41 patients with IBC, 7 of the 20 cases of distant metastases were unsuspected before PET/CT examination and Alberini et al., reported that among 62 patients with IBC, 6 of 18 cases of distant metastases were unsuspected before PET/CT was performed.[78] In this case report it can be seen that FDG PET/CT imaging helps us to see beyond the breast and revealed more extensive form of the disease. FDG PET/CT provides additional information or distant metastasis about disease and it should be considered in the initial staging of IBC. It is also important to distinguish IBC from other types of breast cancers because of major differences in its symptoms, prognosis, and treatment.[910]
  10 in total

Review 1.  Inflammatory breast cancer.

Authors:  Wendy A Woodward; Massimo Cristofanilli
Journal:  Semin Radiat Oncol       Date:  2009-10       Impact factor: 5.934

Review 2.  Inflammatory breast cancer: what are the treatment options?

Authors:  Maria D Iniesta; Colin J Mooney; Sofia D Merajver
Journal:  Expert Opin Pharmacother       Date:  2009-12       Impact factor: 3.889

Review 3.  Inflammatory breast cancer: novel preoperative therapies.

Authors:  Beth A Overmoyer
Journal:  Clin Breast Cancer       Date:  2010-02       Impact factor: 3.225

4.  18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.

Authors:  Jean-Louis Alberini; Florence Lerebours; Myriam Wartski; Emmanuelle Fourme; Elise Le Stanc; E Gontier; O Madar; P Cherel; A P Pecking
Journal:  Cancer       Date:  2009-11-01       Impact factor: 6.860

Review 5.  Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings.

Authors:  Wei T Yang; Huong T Le-Petross; Homer Macapinlac; Selin Carkaci; Ana M Gonzalez-Angulo; Shaheenah Dawood; Erika Resetkova; Gabriel N Hortobagyi; Massimo Cristofanilli
Journal:  Breast Cancer Res Treat       Date:  2007-07-26       Impact factor: 4.872

6.  Breast cancer staging in a single session: whole-body PET/CT mammography.

Authors:  Till A Heusner; Sherko Kuemmel; Lale Umutlu; Angela Koeninger; Lutz S Freudenberg; Elke A M Hauth; Klaus R Kimmig; Michael Forsting; Andreas Bockisch; Gerald Antoch
Journal:  J Nucl Med       Date:  2008-07-16       Impact factor: 10.057

Review 7.  The epidemiology of inflammatory breast cancer.

Authors:  Paul H Levine; Carmela Veneroso
Journal:  Semin Oncol       Date:  2008-02       Impact factor: 4.929

8.  Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data.

Authors:  Selin Carkaci; Homer A Macapinlac; Massimo Cristofanilli; Osama Mawlawi; Eric Rohren; Ana M Gonzalez Angulo; Shaheenah Dawood; Erika Resetkova; Huong T Le-Petross; Wei-Tse Yang
Journal:  J Nucl Med       Date:  2009-01-21       Impact factor: 10.057

9.  The role of PET/CT for evaluating breast cancer.

Authors:  Sang Kyu Yang; Nariya Cho; Woo Kyung Moon
Journal:  Korean J Radiol       Date:  2007 Sep-Oct       Impact factor: 3.500

10.  Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.

Authors:  Shigeto Ueda; Hitoshi Tsuda; Hideki Asakawa; Jiro Omata; Kazuhiko Fukatsu; Nobuo Kondo; Tadaharu Kondo; Yukihiro Hama; Katsumi Tamura; Jiro Ishida; Yoshiyuki Abe; Hidetaka Mochizuki
Journal:  BMC Cancer       Date:  2008-06-09       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.